Skip to the page

Data / Form D filings / Celnyx, Inc.

Celnyx, Inc.: Form D filing

Celnyx, Inc., a biotechnology company in Destin, FL, filed a Form D with the SEC in 2009. The latest, on August 21, 2009, reports $3 million sold of a $4.5 million offering to 24 investors.

Find out what Celnyx, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1234 AIRPORT ROAD, SUITE 105, Destin, FL, 32541
Phone
(850) 650-1010
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Florida
Year incorporated
2009
Revenue range
No Revenues
Exemptions claimed
Rule 505, Rule 506, Securities Act section 4(6)
SEC identifier (CIK)
1469279

The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 21, 2009New notice$4,500,000$3,000,000$1,500,00024Aug 6, 2009sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Parker H. PetitDirector
Dr. Woo-Chul MoonExecutive Officer, Director
Thomas R. BecnelExecutive Officer, Director
Steve GorlinExecutive Officer, Director
Dr. Kwang Kook KimDirector
William SpierDirector

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Aug 17, 2009 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Celnyx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.